PIK3CA mutations can be detected through various genetic testing methods, including PCR-based assays, next-generation sequencing (NGS), and liquid biopsy techniques. These tests are crucial for personalized treatment approaches and can be performed on tumor tissue or circulating tumor DNA (ctDNA) from blood samples.
